Your browser doesn't support javascript.
loading
Neuromyelitis optica: Contribution of therapeutic responses markers monitoring in patients given rituximab.
Romero, G; Ticchioni, M; Cohen, M; Rosenthal-Allieri, M A; Mondot, L; Lebrun Frenay, C.
Afiliação
  • Romero G; Service de neuro-onco-immunologie, hôpital Pasteur 2, CHU de Nice, 30, voie Romaine, 06002 Nice, France. Electronic address: gwendoline.romero@orange.fr.
  • Ticchioni M; Service d'immunologie, hôpital de l'Archet 1, 151, route de Saint-Antoine-de-Ginestière, 06200 Nice, France.
  • Cohen M; Service de neuro-onco-immunologie, hôpital Pasteur 2, CHU de Nice, 30, voie Romaine, 06002 Nice, France.
  • Rosenthal-Allieri MA; Service d'immunologie, hôpital de l'Archet 1, 151, route de Saint-Antoine-de-Ginestière, 06200 Nice, France.
  • Mondot L; Service de radiologie, hôpital Pasteur 2, CHU de Nice, 30, voie Romaine, 06002 Nice, France.
  • Lebrun Frenay C; Service de neuro-onco-immunologie, hôpital Pasteur 2, CHU de Nice, 30, voie Romaine, 06002 Nice, France.
Rev Neurol (Paris) ; 172(3): 220-4, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26915311
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuromielite Óptica / Rituximab / Imunossupressores Tipo de estudo: Guideline Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuromielite Óptica / Rituximab / Imunossupressores Tipo de estudo: Guideline Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article